This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Joint Stock Company "Biocad". Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Vladimir Sergeevich Tsympilov: Innovator in Biotechnology
Introduction
Vladimir Sergeevich Tsympilov is a notable inventor based in Zakulta, Russia. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on innovative solutions that address medical challenges.
Latest Patents
Tsympilov holds a patent for a monoclonal antibody that binds specifically to GITR. This invention relates to biotechnology, specifically to antibodies or antigen-binding fragments and their applications. The patent details a nucleic acid encoding the antibody, an expression vector, and methods for preparing the antibody. It also discusses the use of this antibody in treating diseases or disorders associated with GITR.
Career Highlights
Throughout his career, Tsympilov has demonstrated a commitment to advancing biotechnological research. His innovative approach has led to the development of solutions that have the potential to improve patient outcomes in various medical conditions.
Collaborations
Some of his notable coworkers include Andrei Borisovich Ulitin and Olesya Nikolaevna Kozlova. Their collaborative efforts have contributed to the success of Tsympilov's research and innovations.
Conclusion
Vladimir Sergeevich Tsympilov is a prominent figure in the field of biotechnology, with a focus on monoclonal antibodies. His contributions have the potential to impact medical treatments significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile